6.850SEK+2.24%Mkt Cap: 41.60M $P/E: —Today
Mendus AB (publ), a biopharmaceutical company, develops immunotherapies for the treatment of myeloid blood cancers. The company's lead product is vididencel (DCP-001), which is in Phase II ADVANCE-II clinical trial for t…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$61.34BUSDP/E 39.8
$45.95BUSDP/E 19.6
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.26BUSDP/E 26.6
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap41.60M $
Enterprise Value34.38M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-10.83M $
Revenue/Share—
Last Price6.850 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees19
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-13.80
PEG—
EV/EBITDA-3.74
EV/Revenue—
P/S—
P/B0.74
EPS (TTM)-1.90
EPS (Forward)-0.49
52W Range
3.86049% of range10.02
52W High10.02 SEK
52W Low3.860 SEK
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-19.36%
ROA-18.03%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.80M $
CapEx (TTM)29.37K $
FCF Margin—
FCF Yield-5.20%
Net Debt-5.30M $
Net Debt/EBITDA0.58
Balance Sheet
Debt/Equity0.03
Current Ratio1.52
Quick Ratio1.46
Book Value/Sh9.140 SEK
Cash/Share1.199 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJun 3, 2024
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)33.00 SEK
Upside (mean)+381.8%
Target Range16.00 SEK – 50.00 SEK
SEK16.00+381.8% to meanSEK50.00
# Analysts2
Ownership
Shares Out.63.48M
Float22.35M
Insiders61.92%
Institutions15.62%
Technical
SMA 506.401 (+7.0%)
SMA 2005.440 (+25.9%)
Beta0.76
S&P 52W Chg18.16%
Avg Vol (30d)20.45K
Avg Vol (10d)22.40K
Technical Indicators
RSI (14)51.8
MACD0.1106
MACD Signal0.1451
MACD Hist.-0.0345
BB Upper7.067 SEK
BB Middle6.771 SEK
BB Lower6.475 SEK
BB Width8.75%
ATR (14)0.3910 SEK
Vol Ratio (20d)2.30x